The First Report of a Real-world Experience with a PCSK9 Inhibitor in a Large Familial Hyperlipidemia and Very-high-risk Middle Eastern Population.
Clinical Therapeutics（2022）
关键词
atherosclerotic cardiovascular disease,diabetes mellitus,evolocumab,familial hypercholesterolemia,LDL-C,PCSK9 inhibitor,real-world experience
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要